7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Reaffirming CF Industries at Neutral

by Zacks Equity Research

November 23, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are retaining our Neutral recommendation on CF Industries Holdings Inc. ( CF - Analyst Report ) . Third-quarter 2012 revenues and earnings beat the Zacks Consensus Estimates. Lower nitrogen volumes and a decline in phosphate product prices led to a roughly 3% year-over-year decline in sales in the quarter. Sales volume dipped due to lower urea sales.
Revenues from the core Nitrogen segment remained flat, while sales from the Phosphate division fell 8% in the quarter. Gross margin in the Nitrogen segment jumped 16%, helped by lower natural gas costs. However, margins shrank 26% in the Phosphate unit due to lower average selling prices.
CF Industries remains positive for the remainder of 2012 as well as 2013 based on high corn planting expectations for 2013, strong domestic fertilizer demand, tight domestic nitrogen supply and favorable natural gas costs.
Illinois-based CF Industries is one of the largest manufacturers and distributors of nitrogenous and phosphatic fertilizer products globally. The company became the global producer of nitrogen fertilizers following its $4.7 billion buyout of Terra Industries in April 2010.
CF Industries is benefiting from high global prices for commodities, declining natural gas costs in North America and a solid start to the domestic planting season. Moreover, the company has a strong cash flow profile, which allows it to return value to shareholders and invest in growth initiatives.
Falling natural gas prices have been a boon for CF Industries. The company’s Nitrogen segment is reaping the benefit of abundant natural gas supply, driven by increased production of North American shale gas and favorable weather. Cost of natural gas fell roughly 25% in the third quarter.
Moreover, CF Industries is expected to benefit from strong U.S. corn plantations. Roughly 97 million acres of corn are expected to be planted in 2013, thereby driving the demand for crop nutrients, in particular, nitrogen.
However, CF Industries faces intense pricing competition from both domestic and foreign fertilizer producers. Its domestic competitors such as Agrium Inc. ( AGU - Analyst Report ) and Potash Corp. of Saskatchewan Inc. ( POT - Analyst Report ) holds significant command in the marketplace.
CF Industries is susceptible to cyclical and seasonal changes. The prices of its products are highly sensitive to demand and supply. It is also exposed to volatility in raw material costs and has significant debt.
CF Industries currently retains a Zacks #2 Rank, which translates into a short-term Buy rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.